Earnings History Data for Petros Pharmaceuticals, Inc. (PTPI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. Petros Pharmaceuticals Inc., formerly known as Neurotrope Inc., is based in NEW YORK.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
01-04-2022 PM PTPI Petros Pharmaceuticals, Inc. 32.27 -0.72 0.00 0.00 Petros Pharmaceuticals GAAP EPS of -$0.83, revenue of $7.81M
[4/1/2022 7:33 AM]
1.38 -0.08 
(-5.48%)
1.41 -0.05 
(-3.42%)
1.05 - 5.20 332,844 660,000 9,142
15-11-2021 AH PTPI Petros Pharmaceuticals, Inc. 28.14 -0.17 0.00 0.00 Petros Pharmaceuticals reports Q3 results
[11/15/2021 5:25 PM]
1.71 -0.47 
(-21.56%)
1.92 -0.26 
(-11.93%)
1.56 - 5.96 885,933 30,250,000 62,010
17-08-2021 PM PTPI Petros Pharmaceuticals, Inc. 29.49 -0.45 0.00 -0.65 Petros Pharmaceuticals reports Q2 results
[8/17/2021 9:32 AM]
2.51 -0.20 
(-7.38%)
2.89 0.18 
(6.64%)
1.80 - 5.96 40,347 40,000 804